Order Article Reprints

Camarda L, Corazza I, Locatelli A, Leoni A, Frosini M, Budriesi R, Carosati E, Santini A, Montagnani M, Marzetti C, et al. Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility. Pharmaceuticals. 2025; 18(10):1476. https://doi.org/10.3390/ph18101476

Camarda, Luca, Ivan Corazza, Alessandra Locatelli, Alberto Leoni, Maria Frosini, Roberta Budriesi, Emanuele Carosati, Alberto Santini, Marco Montagnani, Carla Marzetti, and et al. 2025. "Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility" Pharmaceuticals 18, no. 10: 1476. https://doi.org/10.3390/ph18101476

Camarda, L., Corazza, I., Locatelli, A., Leoni, A., Frosini, M., Budriesi, R., Carosati, E., Santini, A., Montagnani, M., Marzetti, C., & Mattioli, L. B. (2025). Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility. Pharmaceuticals, 18(10), 1476. https://doi.org/10.3390/ph18101476